Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

35.73
Delayed Data
As of Jan 13
 +0.47 / +1.33%
Today’s Change
30.89
Today|||52-Week Range
57.81
-0.36%
Year-to-Date

Today’s Trading

Previous close35.26
Today’s open35.76
Day’s range35.56 - 35.95
Volume2,315,202
Average volume (3 months)3,902,951
Market cap$70.0B
Dividend yield2.54%
Data as of 4:02pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.30%
Revenue growth (last year)+1.43%
P/E ratio2.4
Price/Sales9.38
Price/Book13.32

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.21+0.52%
AZNAstraZeneca+0.34+1.20%
AGNAllergan-0.10-0.05%
LLYEli Lilly and Co+0.25+0.32%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts


Search for Jobs